[Mitosis activity and chromosome analysis in peripheral lymphocytes of ALG-treated patients].
D000328:Adult; D000372:Agglutination Tests; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002875:Chromosomes; D003601:Cytotoxicity Tests, Immunologic; D003882:Dermatomyositis / Q000097:blood / Q000188:drug therapy / Q000276:immunology; D005260:Female; D005826:Genetics, Medical; D006736:Horses; D006801:Humans; D007122:Immunoelectrophoresis; D007275:Injections, Intravenous; D007621:Karyotyping; D037102:Lectins / Q000494:pharmacology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000166:cytology* / Q000187:drug effects / Q000276:immunology; D008297:Male; D008938:Mitosis / Q000187:drug effects; D009103:Multiple Sclerosis / Q000097:blood / Q000188:drug therapy / Q000276:immunology; D011123:Polyploidy
D000961:Antilymphocyte Serum; D037102:Lectins
Mitoseaktivität und Chromosomenanalyse in peripheren Lymphocyten ALG-behandelter Patienten.